The Latest Breaking News from Horizon

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

He’s ruling his newest acquisition the way he rules the rest of his empire: impulsively, erratically, vindictively, loudly. It really doesn’t need to be this way.

Horizon Therapeutics, whose U.S. headquarters is in Deerfield, is a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases.

Amgen announced a $28.3 billion plan to acquire Horizon Therapeutics on Monday, leading HZNP stock to soar higher.

The Dow Jones Industrial Average rose Monday morning, as investors prepared for more inflation data and the Fed meeting this week.

Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, for about $26.4 billion

Making a statement on the GLO (group litigation order) compensation scheme, Grant Shapps set out further details in the Commons for MPs.

Johnson & Johnson dropped out of the bidding process for Horizon Therapeutics, pushing HZNP stock into the red on Monday.

"It is going to allow the volunteer-based clubs and some resort clubs, who shut their pro-shop early, to have unlimited access for players."

Horizon is considering potential offers from three Big Pharma stalwarts, sending HZNP stock soaring more than 25% early Wednesday.

Graham Hancock’s new Netflix documentary, about an advanced ancient civilisation that was wiped off the face of the Earth, has been accused by scientists and reviewers of espousing a ‘dangerous’ conspiracy theory. The value of the UK’s independently regulated broadcasters has never seemed clearer in comparison, writes Louis Chilton